← Braze, Inc.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net loss (including amounts attributable to redeemable non-controlling interests) | ($31.8m) | ($32.0m) | ($78.2m) | ($140.7m) | ($130.4m) | ($104.0m) | ($130.8m) | — | |
| Amortization of deferred contract costs | $5.8m | $10.6m | $17.7m | $23.6m | $29.8m | $35.0m | $41.3m | — | |
| Depreciation and amortization | $645k | $1.6m | $2.8m | $4.6m | $7.0m | $10.1m | $19.3m | $23.0m | |
| Stock-based compensation | $12.4m | $7.5m | $47.2m | $72.2m | $97.2m | $115.1m | $143.7m | $148.9m | |
| Stock-based compensation capitalized to internal-use software | $38k | $126k | $387k | $1.1m | $2.2m | $2.3m | $2.1m | $148.9m | |
| Accounts receivable | ($12.6m) | ($12.4m) | ($29.8m) | ($14.7m) | ($14.0m) | ($5.4m) | ($22.7m) | ($28.0m) | |
| Accounts payable | ($2.6m) | ($776k) | $1.6m | $906k | $3.4m | ($3.9m) | ($601k) | $4.2m | |
| Net change to property and equipment (included in accounts payable / accrued liabilities) | $57k | ($15k) | ($23k) | $75k | $208k | $173k | ($259k) | — | |
| Accrued expenses and other current liabilities | $8.2m | $13.8m | $6.0m | $5.1m | $21.0m | $3.7m | $26.2m | — | |
| Deferred revenue | $28.5m | $23.4m | $51.5m | $39.9m | $34.1m | $35.9m | $57.1m | — | |
| Other | — | $60k | ($80k) | $495k | ($349k) | ($152k) | ($144k) | — | |
| Prepaid expenses and other current assets | ($3.0m) | ($833k) | ($17.5m) | $3.6m | ($3.4m) | ($6.6m) | $3.6m | — | |
| Other assets | $25k | $643k | ($4.7m) | $1.7m | $229k | ($29k) | ($1.9m) | — | |
| Net cash provided by operating activities | ($7.4m) |
($6.1m)
+17.45%
|
($35.4m)
-482.20%
|
($22.3m)
+36.98%
|
$6.8m
+130.71%
|
$36.7m
+435.47%
|
$71.4m
+94.76%
|
$75.4m
+5.57%
|
|
| Purchases of property and equipment | ($1.7m) | ($2.5m) | ($2.3m) | ($15.4m) | ($9.8m) | ($13.2m) | ($9.6m) | ($13.4m) | |
| Accretion of discount on marketable securities | — | $345k | $369k | $1.3m | ($2.1m) | ($2.1m) | ($951k) | — | |
| Purchases of marketable securities | ($123.1m) | ($59.4m) | ($36.9m) | ($638.2m) | ($248.1m) | ($218.0m) | ($151.6m) | — | |
| Maturities of marketable securities | $38.5m | $86.2m | $59.3m | $256.4m | $257.7m | $195.4m | $175.2m | — | |
| Return of principal on marketable securities | — | — | — | $0 | $0 | $3.2m | $120.7m | — | |
| Net cash used in investing activities | ($87.2m) | $22.5m | $18.0m | ($398.5m) | ($20.0m) | ($36.5m) | ($50.9m) | ($130.9m) | |
| Value of common stock donated to charity | — | $0 | $0 | $4.3m | $3.8m | $3.8m | $3.2m | — | |
| Proceeds from exercise of common stock options | $1.3m | $2.8m | $8.4m | $11.3m | $7.3m | $6.9m | $15.9m | — | |
| Common stock issuance, acquisition | — | — | $0 | $0 | ($6.1m) | $0 | ($107.6m) | $1.5m | |
| Net cash provided by financing activities | $1.3m |
$4.9m
+287.11%
|
$467.9m
+9515.91%
|
$11.3m
-97.58%
|
$13.1m
+15.68%
|
$11.7m
-10.79%
|
$23.0m
+96.32%
|
($27.3m)
-219.05%
|
|
| Cash, cash equivalents, and restricted cash, beginning of period | $11.6m | $33.0m | $483.0m | $72.6m | $72.1m | $83.6m | $128.3m | — | |
| Effect of foreign currency exchange rate changes on cash, cash equivalents, and restricted cash | $15k | $158k | ($597k) | ($855k) | ($475k) | ($444k) | $1.3m | — | |
| Net change in cash, cash equivalents, and restricted cash | ($93.3m) | $21.4m | $450.0m | ($410.4m) | ($492k) | $11.5m | $44.7m | — | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Provision for credit losses | $580k | $853k | $88k | $807k | $2.0m | $2.3m | $666k | — | |
| Non-cash foreign exchange (gain) loss | $212k | $222k | $387k | $1.6m | $460k | ($1.0m) | ($73k) | — | |
| Fair value adjustments to contingent consideration | — | — | $0 | $0 | ($1.6m) | ($223k) | $0 | — | |
| Fixed asset write offs | — | — | — | $34k | $146k | $488k | $80k | — | |
| Deferred contract costs | ($14.6m) | ($20.0m) | ($32.0m) | ($30.5m) | ($45.1m) | ($48.2m) | ($65.2m) | — | |
| ROU assets and liabilities | — | $0 | $0 | $3.4m | $4.3m | $1.9m | ($1.1m) | — | |
| Other long-term liabilities | $1.2m | $777k | ($756k) | $10k | $571k | ($66k) | ($229k) | — | |
| Cash paid for acquisition, net of cash acquired | — | — | $0 | $0 | ($16.3m) | $0 | ($181.9m) | — | |
| Capitalized internal-use software costs | ($830k) | ($1.9m) | ($2.1m) | ($1.3m) | ($3.6m) | ($3.8m) | ($3.8m) | — | |
| Proceeds from stock associated with employee stock purchase plan | — | — | ($5.2m) | $0 | $0 | $7.7m | $7.1m | — | |
| Payments of deferred purchase consideration | — | — | — | $0 | ($165k) | ($2.9m) | $0 | — | |
| Cash paid for income taxes, net of refunds | $176k | $472k | $299k | $365k | $309k | $2.9m | $3.9m | — | |
| Unrealized net gain on marketable investment securities | $87k | ($50k) | ($64k) | ($5.6m) | $5.4m | $1.1m | $483k | — | |
| Asset retirement obligation | — | $0 | $0 | $374k | $62k | $34k | $38k | — | |
| Contingent consideration, acquisition | — | — | $0 | $0 | ($1.8m) | $0 | $0 | — | |
| Indemnity escrows, acquisition | — | — | $0 | $0 | ($3.1m) | $0 | ($3.1m) | — |